Discover
KYNB
Kyntra Bio, Inc.
6.11
1 x 6.96
1 x 6.83
bid
ask
+
0.15
2.52%
1 @ 04:00 PM
6.11 +0.00 (0.00%)
| Ytd | -30.41% | |
| 1y | -44.25% |
6.08
day range
6.26
5.96
52 week range
11.18
| Open | 6.08 | Prev Close | 5.96 | Low | 6.08 | High | 6.26 | Mkt Cap | 24.74M |
| Vol | 6.57K | Avg Vol | 18.29K | EPS | -7.91 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.05 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 7.27 | 200-d Avg | 7.41 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | -1.47M | ||
| Revenues (USD) | -1.47M | ||
| Cost of Revenue | 2.00K | ||
| Gross Profit | -1.48M | ||
| Operating Expenses | 16.10M | ||
| Research and Development Expense | 6.82M | ||
| Selling, General and Administrative Expense | 9.27M | ||
| Operating Income | -17.57M | ||
| Interest Expense | 2.37M | ||
| Income Tax Expense | -1000 | ||
| Net Income | 11.97M | ||
| Net Income Common Stock | 11.97M | ||
| Net Income Common Stock (USD) | 11.97M | ||
| Consolidated Income | 11.97M | ||
| Earnings per Basic Share | 2.96 | ||
| Earnings per Basic Share (USD) | 2.96 | ||
| Earnings per Diluted Share | 2.96 | ||
| Earning Before Interest & Taxes (EBIT) | 14.34M | ||
| Earning Before Interest & Taxes (USD) | 14.34M | ||
| Weighted Average Shares | 4.05M | ||
| Weighted Average Shares Diluted | 4.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 50.64M | ||
| Cash and Equivalents (USD) | 50.64M | ||
| Investments | 44.69M | ||
| Investments Current | 40.67M | ||
| Investments Non-Current | 4.01M | ||
| Trade and Non-Trade Receivables | 347.00K | ||
| Current Assets | 96.83M | ||
| Total Assets | 101.08M | ||
| Total Debt | 70.50M | ||
| Current Liabilities | 36.04M | ||
| Debt Non-Current | 70.50M | ||
| Total Liabilities | 109.22M | ||
| Accumulated Retained Earnings (Deficit) | -1.71B | ||
| Accumulated Other Comprehensive Income | -1.19M | ||
| Shareholders Equity | -30.14M | ||
| Shareholders Equity (USD) | -30.14M | ||
| Assets Non-Current | 4.25M | ||
| Total Debt (USD) | 70.50M | ||
| Deferred Revenue | 8.04M | ||
| Inventory | 3.38M | ||
| Liabilities Non-Current | 73.18M | ||
| Trade and Non-Trade Payables | 7.51M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.00K | ||
| Net Cash Flow from Financing | -5.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 13.65M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 3.99M | ||
| Net Cash Flow from Investing | 17.67M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 13.68M | ||
| Net Cash Flow from Operations | -3.99M | ||
| Effect of Exchange Rate Changes on Cash | -30.00K | ||
| Share Based Compensation | 984.00K | ||